Julie M. Cherrington - Jan 18, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Director
Signature
/s/ Reena Desai, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Jan 18, 2023
Transactions value $
-$113,704
Form type
4
Date filed
1/20/2023, 08:20 AM
Previous filing
Aug 8, 2022
Next filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$114K -2.55K -100% $44.66 0 Jan 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2021.